A. K. House

1.2k total citations
57 papers, 1.0k citations indexed

About

A. K. House is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, A. K. House has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 18 papers in Pulmonary and Respiratory Medicine and 14 papers in Immunology. Recurrent topics in A. K. House's work include Colorectal Cancer Treatments and Studies (6 papers), Macrophage Migration Inhibitory Factor (6 papers) and Immune Response and Inflammation (5 papers). A. K. House is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Macrophage Migration Inhibitory Factor (6 papers) and Immune Response and Inflammation (5 papers). A. K. House collaborates with scholars based in Australia, United Kingdom and United States. A. K. House's co-authors include B Iacopetta, Brett R. Dix, Paul Robbins, Robert L. Moritz, Peter J. Mark, Richard J. Simpson, Amerigo Carrello, T. Ratajczak, Karin Allenspach and Dirk Werling and has published in prestigious journals such as Journal of Biological Chemistry, Cancer and Gut.

In The Last Decade

A. K. House

53 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. K. House Australia 14 366 307 248 227 219 57 1.0k
Robert L. Young United States 20 329 0.9× 377 1.2× 283 1.1× 126 0.6× 563 2.6× 34 2.2k
B Golematis Greece 17 210 0.6× 163 0.5× 80 0.3× 166 0.7× 413 1.9× 70 899
William Kopp United States 15 280 0.8× 189 0.6× 351 1.4× 186 0.8× 76 0.3× 26 978
S. Gullini Italy 18 175 0.5× 234 0.8× 240 1.0× 87 0.4× 696 3.2× 47 1.2k
John B. Miller United States 15 215 0.6× 195 0.6× 234 0.9× 296 1.3× 99 0.5× 40 961
Heiko Rühl Germany 19 264 0.7× 317 1.0× 320 1.3× 147 0.6× 64 0.3× 92 1.8k
R. Botella Spain 18 301 0.8× 142 0.5× 271 1.1× 142 0.6× 168 0.8× 76 1.1k
María Ortiz Spain 19 335 0.9× 648 2.1× 179 0.7× 94 0.4× 175 0.8× 59 1.2k
Emilia Saraga Switzerland 23 555 1.5× 273 0.9× 295 1.2× 456 2.0× 881 4.0× 37 1.8k
Sílvia Helena Barem Rabenhorst Brazil 19 207 0.6× 348 1.1× 115 0.5× 117 0.5× 268 1.2× 89 1.0k

Countries citing papers authored by A. K. House

Since Specialization
Citations

This map shows the geographic impact of A. K. House's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. K. House with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. K. House more than expected).

Fields of papers citing papers by A. K. House

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. K. House. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. K. House. The network helps show where A. K. House may publish in the future.

Co-authorship network of co-authors of A. K. House

This figure shows the co-authorship network connecting the top 25 collaborators of A. K. House. A scholar is included among the top collaborators of A. K. House based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. K. House. A. K. House is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hendricks, Anke, et al.. (2012). Ciclosporin modulates the responses of canine progenitor epidermal keratinocytes (CPEK) to toll-like receptor agonists. Veterinary Immunology and Immunopathology. 147(1-2). 91–96. 15 indexed citations
2.
Kathrani, Aarti, A. K. House, Briän Catchpole, et al.. (2011). Breed‐independent toll‐like receptor 5 polymorphisms show association with canine inflammatory bowel disease. Tissue Antigens. 78(2). 94–101. 35 indexed citations
3.
Pelligand, Ludovic, A. K. House, Brian A. Summers, et al.. (2011). Development and validation of a tissue cage model of acute inflammation in the cat. Journal of Veterinary Pharmacology and Therapeutics. 35(3). 239–248. 9 indexed citations
4.
Allenspach, Karin, A. K. House, Ken Smith, et al.. (2010). Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German shepherd dogs with chronic enteropathies. Veterinary Microbiology. 146(3-4). 326–335. 91 indexed citations
5.
Leong, Rupert W., G. Jeffrey, David W. Smith, et al.. (2001). Effectiveness of Cytomegalovirus prophylaxis following liver transplantation. Immunology and Cell Biology. 79(4). 10. 1 indexed citations
6.
Elsaleh, Hany, et al.. (1999). TP53 gene mutation status in pretreatment biopsies of oesophageal adenocarcinoma has no prognostic value. European Journal of Cancer. 35(12). 1683–1687. 11 indexed citations
7.
Soong, Richie, Fabienne Grieu, Paul Robbins, et al.. (1997). p53 alterations are associated with improved prognosis in distal colonic carcinomas.. PubMed. 3(8). 1405–11. 92 indexed citations
8.
Wysocki, S.J., et al.. (1997). Morphometric changes seen in balloon-injured porcine iliac arteries: The influence of sympthectomy on intimal hyperplasia and remodelling. European Journal of Vascular and Endovascular Surgery. 13(1). 43–47. 9 indexed citations
9.
Bell, Robin J., et al.. (1995). Short-term and Long-Term Outcome following Renovascular Reconstruction. Cardiovascular Surgery. 3(1). 50–55. 1 indexed citations
10.
Iacopetta, B, et al.. (1994). Loss of heterozygosity of tumour suppressor gene loci in human colorectal carcinoma. European Journal of Cancer. 30(5). 664–670. 28 indexed citations
11.
Norman, Paul E. & A. K. House. (1990). Surgical complications of fulminating meningococcaemia. International Journal of Clinical Practice. 44(1). 36–37. 4 indexed citations
12.
Agrez, Michael, et al.. (1988). PROGNOSTIC SIGNIFICANCE OF LYMPHATIC PERMEATION IN DUKES' B COLORECTAL CANCER. Australian and New Zealand Journal of Surgery. 58(1). 39–42. 6 indexed citations
13.
House, A. K. & Moira Maley. (1986). Colorectal carcinoma in a rat model: Suppression of tumour development and altered host immune status following treatment with anti B-lymphocyte serum. Journal of Surgical Oncology. 32(4). 256–262. 2 indexed citations
14.
House, A. K. & Moira Maley. (1984). Immune capability of rats with colorectal carcinoma treated by resection with or without 5‐fluorouracil or levamisole. Journal of Surgical Oncology. 27(3). 172–178. 1 indexed citations
15.
Maley, Moira & A. K. House. (1983). The immune status of the rat with carcinoma of the bowel.. PubMed. 64(3). 245–51. 5 indexed citations
16.
Knuckey, N., et al.. (1982). CYSTIC DEGENERATION OF THE POPLITEAL ARTERY. Australian and New Zealand Journal of Surgery. 52(6). 581–584. 2 indexed citations
17.
House, A. K., et al.. (1979). Survival and the immune response in patients with carcinoma of the colorectum.. Gut. 20(10). 868–874. 40 indexed citations
19.
Brockis, J. G., et al.. (1975). The Management of Urinary Fistulae following Cadaveric Renal Transplantation. British Journal of Urology. 47(4). 371–375. 2 indexed citations
20.
House, A. K., J L Boak, & B. Hulme. (1972). An in vitro study of renal allograft recipients for cellular delayed type hypersensitivity to glomerular basement membrane and disrupted spleen cells.. PubMed Central. 11(2). 165–72. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026